This inventor holds 4 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2025
Title: Valentyn Antochshuk: Innovator in Antibody Formulations
Introduction
Valentyn Antochshuk is a notable inventor based in Cranford, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. With a total of 4 patents to his name, his work focuses on innovative solutions for treating various disorders.
Latest Patents
Antochshuk's latest patents include groundbreaking inventions such as co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies. This invention provides co-formulations that are essential for treating a range of disorders. Additionally, he has developed formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies, which also aim to address various medical conditions.
Career Highlights
Valentyn Antochshuk is currently associated with Merck Sharp & Dohme Corporation, where he continues to push the boundaries of medical research and innovation. His work has been instrumental in advancing therapeutic options for patients.
Collaborations
Throughout his career, Antochshuk has collaborated with talented individuals such as Preeti G Desai and Shuai Shi. These partnerships have contributed to the success of his projects and the advancement of their shared goals in the field of biotechnology.
Conclusion
Valentyn Antochshuk stands out as a prominent inventor in the realm of antibody formulations. His innovative patents and collaborations reflect his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile